Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antidiabetic SGLT-2 Inhibitor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antidiabetic SGLT-2 Inhibitormarket, defines the market attractiveness level of Antidiabetic SGLT-2 Inhibitor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antidiabetic SGLT-2 Inhibitor industry, describes the types of Antidiabetic SGLT-2 Inhibitor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antidiabetic SGLT-2 Inhibitor market and the development prospects and opportunities of Antidiabetic SGLT-2 Inhibitor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antidiabetic SGLT-2 Inhibitor market in Chapter 13.
By Player:
Pfizer
Bristol-Myers Squibb
Servier Laboratories
Novo Nordisk
AstraZeneca
Johnson & Johnson
GlaxoSmithKline
Takeda Pharmaceuticals
Boehringer Ingelheim
Merck & Co
Eli Lilly
Sanofi
By Type:
Canagliflozin
Empagliflozin
Dapagliflozin
Other
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antidiabetic SGLT-2 Inhibitor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antidiabetic SGLT-2 Inhibitor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antidiabetic SGLT-2 Inhibitor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antidiabetic SGLT-2 Inhibitor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antidiabetic SGLT-2 Inhibitor Market Analysis and Outlook to 2022
-
7.1 Global Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
-
7.2 United States Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
-
7.3 Europe Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
-
7.4 China Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
-
7.5 Japan Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
-
7.6 India Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
-
7.7 South Korea Antidiabetic SGLT-2 Inhibitor Consumption (2017-2022)
8 Region and Country-wise Antidiabetic SGLT-2 Inhibitor Market Analysis and Outlook to 2028
-
8.1 Global Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
-
8.2 United States Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
-
8.3 Europe Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
-
8.4 China Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
-
8.5 Japan Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
-
8.6 India Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
-
8.7 South Korea Antidiabetic SGLT-2 Inhibitor Consumption Forecast (2022-2028)
9 Global Antidiabetic SGLT-2 Inhibitor Market Outlook by Types and Applications to 2022
-
9.1 Global Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Canagliflozin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Empagliflozin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dapagliflozin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antidiabetic SGLT-2 Inhibitor Market Outlook by Types and Applications to 2028
-
10.1 Global Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Canagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Empagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dapagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antidiabetic SGLT-2 Inhibitor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antidiabetic SGLT-2 Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antidiabetic SGLT-2 Inhibitor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antidiabetic SGLT-2 Inhibitor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antidiabetic SGLT-2 Inhibitor Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.3 Servier Laboratories
-
14.3.1 Servier Laboratories Company Details
-
14.3.2 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.4 Novo Nordisk
-
14.4.1 Novo Nordisk Company Details
-
14.4.2 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.8 Takeda Pharmaceuticals
-
14.8.1 Takeda Pharmaceuticals Company Details
-
14.8.2 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.10 Merck & Co
-
14.10.1 Merck & Co Company Details
-
14.10.2 Merck & Co Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck & Co Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.11 Eli Lilly
-
14.11.1 Eli Lilly Company Details
-
14.11.2 Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Eli Lilly Antidiabetic SGLT-2 Inhibitor Product and Service
-
14.12 Sanofi
-
14.12.1 Sanofi Company Details
-
14.12.2 Sanofi Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Sanofi Antidiabetic SGLT-2 Inhibitor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antidiabetic SGLT-2 Inhibitor
-
Figure Antidiabetic SGLT-2 Inhibitor Picture
-
Table Global Antidiabetic SGLT-2 Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic SGLT-2 Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic SGLT-2 Inhibitor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antidiabetic SGLT-2 Inhibitor Consumption by Country (2017-2022)
-
Figure United States Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Table Europe Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure China Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Japan Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure India Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antidiabetic SGLT-2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Antidiabetic SGLT-2 Inhibitor Consumption Forecast by Country (2022-2028)
-
Figure United States Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antidiabetic SGLT-2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Canagliflozin Consumption and Growth Rate (2017-2022)
-
Figure Global Empagliflozin Consumption and Growth Rate (2017-2022)
-
Figure Global Dapagliflozin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Canagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Empagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dapagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antidiabetic SGLT-2 Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antidiabetic SGLT-2 Inhibitor Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Servier Laboratories (Foundation Year, Company Profile and etc.)
-
Table Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antidiabetic SGLT-2 Inhibitor Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antidiabetic SGLT-2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antidiabetic SGLT-2 Inhibitor Product and Service
-
